Genetically determined vitamin D levels do not have a large effect on risk of type 1 diabetes in Europeans.
Vitamin D levels do not influence the chance of developing 1 diabetes in Europeans, according to a study published in the open-access journal PLOS Medicine by Despoina Manousaki from the CHU Sainte Justine and the University of Montreal, Canada and colleagues. Type 1 diabetes is a relatively common autoimmune disease that inflicts substantial lifelong illness and significant economic burden.
‘Physicians may not suggest the use of vitamin D supplements as a strategy to prevent type 1 diabetes in individuals at risk.’
Read More..
Its incidence is increasing worldwide, and there are no known interventions that can be used to prevent the disease. Vitamin D deficiency has been associated with type 1 diabetes in observational studies, but evidence of a causal effect from randomized controlled trials is lacking.Read More..
In the new study, the researchers used a Mendelian randomization design to test whether genetically decreased vitamin D levels increase risk of type 1 diabetes. Mendelian randomization is a method of using measured variation in disease-related genes to examine the causal effect of an exposure on a disease.
The two-sample Mendelian randomization study involved a vitamin D genome-wide association study (GWAS) including 443,734 Europeans, and a type 1 diabetes GWAS including 9,358 cases and 15,705 controls.
The results do not support a large effect of vitamin D levels on risk of type 1 diabetes (odds ratio: 1.09, 95% confidence interval: 0.86-1.40, p=0.48). However, smaller effects may exist, and the results may not be applicable to non-European populations.
The findings suggest that the previous epidemiological associations between vitamin D and type 1 diabetes could be due to confounding factors, such as latitude and exposure to sunlight.
Advertisement
Advertisement